NCT01978171View on ClinicalTrials.gov

Prediction of Everolimus-induced Interstitial Lung Disease

CompletedOBSERVATIONAL
Enrollment

27

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

January 15, 2018

Study Completion Date

January 15, 2018

Conditions
Breast Neoplasms
Trial Locations (2)

Unknown

Antonius Ziekenhuis, Nieuwegein

Radboud university medical center, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT01978171 - Prediction of Everolimus-induced Interstitial Lung Disease | Biotech Hunter | Biotech Hunter